Genetics may determine link between aspirin, colon cancer risk
the ONA take:
According to a new study published in the Journal of the American Medical Association (JAMA), researchers have found that a person's individual genetics may determine if a person will have a reduced risk of colon cancer from taking aspirin.
The association between taking aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) and colorectal cancer prevention is well known, but it is not understood why some people benefit from the agents and some do not.
Therefore, researchers from four countries sought to investigate whether there is an association between certain DNA variations and the protection that aspirin confers.
For the study, researchers analyzed the data of over 17,000 people from ten large studies. They identified 8,624 people who developed colorectal cancer and 8,553 people who did not.
Results showed that there was DNA evidence that 1 in 25 people do not benefit from aspirin. Researchers found that those people may actually have an increased risk of developing colorectal cancer if they take aspirin.
A person's individual genetics may determine if a person will have a reduced risk of colon cancer from taking aspirin.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|